How do John Hancock's AED and blood pressure offers aim to reduce heart-related deaths for Vitality members?

The AED access targets faster at-home response and the Index BPM supports self-monitoring for blood pressure control. According to the company, AEDs can raise survivability of in-home cardiac arrests by 40–70% and self-monitoring helps identify high blood pressure early.

John Hancock Convenes Global Leaders in Longevity for Third Longer. Healthier. Better. Symposium in Boston

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Positive)

Rhea-AI Summary

John Hancock (NYSE:MFC) held its third Longer. Healthier. Better. Symposium in Boston on April 13, 2026, convening leaders across science, medicine, policy and athletics to discuss longevity advances.

The company announced new John Hancock Vitality cardiac offerings—discounted in-home AED access via GoRescue and a Garmin Index BPM blood pressure monitor offer—to expand prevention and home-based response for members.

AI-generated analysis. Not financial advice.

News Market Reaction – MFC

+2.08%

1 alert

+2.08% News Effect

On the day this news was published, MFC gained 2.08%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Heart disease share of deaths: 1 in every 5 deaths Adults with heart risk factors: Nearly two-thirds of U.S. adults Out-of-hospital arrests at home: 70 percent +5 more

8 metrics

Heart disease share of deaths 1 in every 5 deaths Cause of death in the U.S.

Adults with heart risk factors Nearly two-thirds of U.S. adults Have at least one heart disease risk factor

Out-of-hospital arrests at home 70 percent Share of out-of-hospital cardiac arrests occurring at home

AED survivability impact 40 to 70 percent Increase in survivability of in-home sudden cardiac arrests

High blood pressure prevalence Nearly half of U.S. adults Adults with high blood pressure

Program duration Over 10 years Length of John Hancock Vitality Program operation

Third symposium Third Longer. Healthier. Better. Symposium Number of times John Hancock has held this event

Two-day event Two days Duration of the Boston longevity symposium

Market Reality Check

Price: $37.57 Vol: Volume 999,644 is below t...

low vol

$37.57 Last Close

Volume Volume 999,644 is below the 20-day average of 1,932,402, suggesting muted trading ahead of this wellness-focused announcement. low

Technical Shares at 36.52 are trading above the 200-day MA of 33.59, and about 5.68% below the 52-week high of 38.72.

Peers on Argus

MFC slipped 0.19% while life-insurance peers were mixed: MET (-0.98%), AFL (-2.1...

MFC slipped 0.19% while life-insurance peers were mixed: MET (-0.98%), AFL (-2.1%), GL (-1.0%), with PRU (+0.2%) and UNM (+0.35%). Moves do not indicate a unified sector trend.

Historical Context

5 past events · Latest: Mar 27 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 27	Annual meeting docs	Neutral	-2.4%	Release of 2026 management circular and 2025 annual report details.
Mar 18	Conference participation	Neutral	-0.7%	CFO fireside chat announcement at a financial services conference.
Mar 10	AI platform partnership	Positive	+1.1%	Selection of Akka to operationalize agentic AI enterprise-wide.
Feb 26	Leadership appointment	Positive	+1.2%	New Head of Emerging Markets Fixed Income with 30+ years’ experience.
Feb 19	Share buyback plan	Positive	+1.4%	Approval of NCIB to repurchase up to 42 million common shares.

Pattern Detected

Recent corporate and capital-management news often saw modest positive reactions when clearly shareholder-friendly (AI value creation, NCIB), while more routine governance disclosures sometimes coincided with mild weakness.

Recent Company History

Over the last few months, Manulife highlighted several strategic and governance developments. A February NCIB to repurchase up to 42 million shares and an AI partnership targeting $1 billion+ in enterprise value by 2027 both drew positive price reactions. Management changes in emerging markets fixed income also coincided with gains. In contrast, routine items like the May 14, 2026 annual meeting circular and conference participation saw small declines. Today’s wellness and longevity symposium extends the brand’s focus on health-oriented insurance offerings rather than capital actions.

Market Pulse Summary

This announcement centers on Manulife’s John Hancock unit expanding its longevity and cardiac-health...

Analysis

This announcement centers on Manulife’s John Hancock unit expanding its longevity and cardiac-health focus through a two-day Boston symposium and new Vitality member benefits such as in-home AED access and smart blood pressure monitoring. It complements earlier initiatives, including an NCIB to repurchase up to 42 million shares and an AI partnership targeting $1 billion+ in value by 2027. Investors may track future disclosures on adoption of these health tools and any quantified impact on engagement or claims experience.

Key Terms

automated external defibrillators, aed, glp-1

3 terms

automated external defibrillators medical

"Access to discounted in-home Automated External Defibrillators (AEDs) from GoRescue."

Automated external defibrillators are portable devices that act like a jump starter for the heart: they detect dangerous heart rhythms and deliver a guided electric shock, with voice and visual prompts, so a bystander can use them safely. Investors track AEDs because they are regulated medical products sold to hospitals, businesses and public venues, so their sales, regulation, maintenance and legal risks affect company revenue and reputation.

aed medical

"AEDs can increase survivability of in-home sudden cardiac arrests by 40 to 70 percent."

AED is the three-letter currency code for the United Arab Emirates dirham, the official money used for prices, contracts and settlements in the UAE. For investors, knowing the currency is like knowing the unit on a scale: exchange-rate moves change the value of foreign earnings, affect cross-border deals and alter comparative returns when converting between currencies, so AED fluctuations can materially affect investment outcomes tied to the UAE.

glp-1 medical

"The GLP-1 inflection point: Dr. Giles Yeo and Dr. Ian Smith will explore the science..."

GLP-1 (glucagon-like peptide-1) is a natural hormone in the body that helps regulate blood sugar levels and appetite. Its significance to investors lies in its role as the basis for a class of medications that address conditions like type 2 diabetes and obesity, which are large and growing markets. Advances or investments in GLP-1-based treatments can signal opportunities in healthcare innovation and potentially impact pharmaceutical companies’ growth.

AI-generated analysis. Not financial advice.

04/13/2026 - 09:30 AM

Massachusetts Governor Maura Healey Joins Speaker Lineup of World-Class Researchers, Scientists, Physicians, Athletes and Innovators

New Cardiac Health Support Tools for John Hancock Vitality Members Announced as Heart Disease Remains Top Cause of Death in U.S.

BOSTON, April 13, 2026 /PRNewswire/ - Today, John Hancock kicks off its third Longer. Healthier. Better. Symposium in Boston, convening global leaders across public and private sectors, renowned academics, physicians, health and wellness thought leaders, athletes, and more, for two days to share the latest research and innovations driving the future of longevity.

The Symposium builds on John Hancock's strategic ambition to empower customer health, wealth, and financial well-being, deepening the firm's mission to help customers live longer, healthier, better lives through more comprehensive insurance and wealth planning solutions that support their evolving needs.

"Our industry – arguably more than any other – is uniquely positioned to play a meaningful role in leading the innovative thinking and developing the solutions required to truly help more Americans live longer, healthier, better lives," said Brooks Tingle, President and CEO of John Hancock. "As people live longer, there is a universal need to improve not just how they save for retirement but how they prepare holistically to spend more years in good health. We're proud to host this Symposium in Boston – a hub of longevity innovation – and convene some of the brightest minds envisioning the future of not just how long we live, but how well we live."

Symposium Program Highlights
In addition to Massachusetts Governor Maura Healey, an impressive lineup of leading academics, scientists, physicians, and athletes, will address breakthroughs in early cancer detection, cognitive longevity, stem cell research, and nutrition science. Program highlights include:

Early detection at scale: Prenuvo CEO Andrew Lacy will discuss whole-body screening and cancer detection; others, including Dr. John Osborne of Clear Cardio, will explore how we can integrate leading-edge early detection technology into mainstream care.
AI-driven breakthroughs: Dr. Siddhartha Mukherjee will cover how AI is moving medicine from symptom management to curative intent, including immune cell design and genetic disease intervention.
The GLP-1 inflection point: Dr. Giles Yeo and Dr. Ian Smith will explore the science of appetite, the evolving nutrition landscape, and the societal forces influencing how individuals navigate health and weight today.
Predictive care via wearables: Oura CEO Tom Hale will discuss remote monitoring, data transparency and building trust in AI-enabled care.

"It's an honor to join John Hancock alongside world-renowned health and longevity experts here in our home state of Massachusetts," said Governor Maura Healey. "The topics being discussed over the course of this Symposium are critical to both our communities and society at large. I'm excited to share the stage with – and even more so hear from – the brilliant minds leading the science and research that will help more people live longer, healthier, better lives."

New Heart Health Offerings
John Hancock is increasing its focus on cardiac health with new offerings for John Hancock Vitality members announced today at the Symposium. Heart disease is the number one cause of death in America, responsible for approximately 1 in every 5 deaths annually. Nearly two-thirds of U.S. adults have at least one risk factor for heart disease, such as high blood pressure, high cholesterol, or obesity. Key prevention includes healthy eating, regular exercise, smoking cessation, and stress management – all focus areas of the John Hancock Vitality Program, which for over 10 years has provided customers with education, tools, incentives and rewards for the everyday things they do to help improve their long-term health.

While prevention efforts are critical to helping prevent heart health-related events, having proper tools in the home can make a profound difference in outcomes, as data shows 70 percent of all out-of-hospital cardiac arrests happen in the home. As part of John Hancock's ongoing commitment to offer customers access to tools and technology to help them live longer, healthier, better lives, the newly announced heart health offerings for John Hancock Vitality members include:

At-Home Defibrillators: Access to discounted in-home Automated External Defibrillators (AEDs) from GoRescue. AEDs can increase survivability of in-home sudden cardiac arrests by 40 to 70 percent.¹
Blood Pressure Monitors: Access to a special offer on the Index™ BPM Smart Blood Pressure Monitor² from Garmin. Nearly half of U.S. adults have high blood pressure, and self-monitoring can help save lives and reduce health care costs.

To learn more about the John Hancock Vitality Program visit www.johnhancock.com.

¹ Discounted access to the AED products and services offered by GoRescue are only available to registered John Hancock Vitality members who have completed the Vitality Health Review (VHR) for the current program year. The offer of discounted access to the AEDs provided by GoRescue is subject to change and is not currently available in all states. John Hancock is not an affiliate of Go Rescue. The AED products and services are provided by GoRescue directly to the John Hancock Vitality member. John Hancock does not provide medical advice, is not involved in the products or services provided by GoRescue and is not responsible for the accuracy or performance of such products or services.

² See Instructions for Use. Index BPM is a stand-alone medical device that measures and displays blood pressure and pulse rate. Index BPM is not intended to diagnose, treat, cure or prevent any disease, and it is not intended for use by children under the age of 18. Index BPM is not available in all regions; see availability."

About John Hancock and Manulife
John Hancock is a unit of Manulife Financial Corporation, a leading international financial services provider that helps people make their decisions easier and lives better by providing financial advice, insurance, and wealth and asset management solutions. Manulife Financial Corporation trades as MFC on the TSX, NYSE, and PSE, and under 945 on the SEHK. Manulife can be found at manulife.com.

One of the largest life insurers in the United States, John Hancock supports more than ten million Americans with a broad range of financial products, including life insurance and annuities. John Hancock also supports US investors by bringing investment capabilities and retirement planning and administration expertise to individuals and institutions. Additional information about John Hancock may be found at johnhancock.com.

Vitality is the provider of the John Hancock Vitality Program in connection with policies issued by John Hancock. John Hancock Vitality Program rewards and discounts are available only to the person insured under the eligible life insurance policy, may vary based on the type of insurance policy purchased and the state where the policy was issued, are subject to change and are not guaranteed to remain the same for the life of the policy. To be eligible to earn rewards and discounts by participating in the Vitality program, the insured must register for Vitality and in most instances also complete the Vitality Health Review (VHR).

Insurance products are issued by: John Hancock Life Insurance Company (U.S.A.), Boston, MA 02116 (not licensed in New York) and John Hancock Life Insurance Company of New York, Valhalla, NY 10595.

Media Contact
news@jhancock.com

MLINY040326048-1

View original content to download multimedia:https://www.prnewswire.com/news-releases/john-hancock-convenes-global-leaders-in-longevity-for-third-longer-healthier-better-symposium-in-boston-302739962.html

SOURCE John Hancock

FAQ

What cardiac health offerings did John Hancock (MFC) announce at the April 13, 2026 symposium?

They announced discounted access to in-home AEDs via GoRescue and a special offer on the Garmin Index BPM blood pressure monitor. According to the company, these offers are for registered John Hancock Vitality members who complete the current program year Vitality Health Review.

Who spoke at John Hancock's Longer. Healthier. Better. Symposium in Boston on April 13, 2026?

Speakers included Governor Maura Healey, Prenuvo CEO Andrew Lacy, Dr. Siddhartha Mukherjee, Dr. Giles Yeo, Dr. Ian Smith, and Oura CEO Tom Hale. According to the company, the lineup spans academics, clinicians, athletes and longevity innovators.

Who is eligible for the GoRescue AED discount through John Hancock Vitality (MFC)?

Discounted access to GoRescue AEDs is available only to registered Vitality members who complete the Vitality Health Review for the current program year. According to the company, availability varies by state and the offer is subject to change.

Does the Garmin Index BPM offered through John Hancock Vitality diagnose conditions?

No, the Index BPM is a stand-alone device that measures and displays blood pressure and pulse but is not intended to diagnose or treat disease. According to the company, it is a self-monitoring tool and availability may be region-limited.

What longevity topics were highlighted at the John Hancock (MFC) symposium that could affect future insurance products?

Sessions covered early cancer detection, AI-driven medicine, GLP-1 and nutrition science, stem cells, and wearable predictive care. According to the company, these topics inform how John Hancock integrates health tools into insurance and wealth planning solutions.